{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:42:54Z","timestamp":1757619774100,"version":"3.44.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s00284-025-04310-1","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T07:45:00Z","timestamp":1753515900000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antibacterial Synergism of Fluoxetine and Paroxetine with Ceftriaxone, Plasmid DNA Cleavage and Repositioning"],"prefix":"10.1007","volume":"82","author":[{"given":"Vit\u00f3ria S.","family":"Foletto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marissa B.","family":"Serafin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Augusto D.","family":"da Mota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taci\u00e9li F.","family":"da Rosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelita","family":"Bottega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara L.","family":"Marion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno R.","family":"de Paula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"La\u00edsa N.","family":"Franco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luana B.","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosmari","family":"H\u00f6rner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,26]]},"reference":[{"key":"4310_CR1","unstructured":"O\u2019Neill J (2014) Antimicrobial Resistance: Tackling a crisis for the health and wealth of nations. Review on Antimicrobial Resistance."},{"key":"4310_CR2","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1164\/rccm.202003-0543OC","volume":"201","author":"Y Du","year":"2020","unstructured":"Du Y, Tu L, Zhu P, Mu M, Wang R, Yang P, Wang X, Hu C, Ping R, Hu P, Li T, Cao F, Chang C, Hu O, Jin Y, Xu G (2020) Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study. Am J Respir Crit Care Med 201:1372\u20131379. https:\/\/doi.org\/10.1164\/rccm.202003-0543OC","journal-title":"Am J Respir Crit Care Med"},{"key":"4310_CR3","unstructured":"Davies S (2011) Annual Report of the Chief Medical Officer. Volume II: Infections and the rise of antibiotic resistance."},{"key":"4310_CR4","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1089\/mdr.2015.0220","volume":"22","author":"E Cerceo","year":"2016","unstructured":"Cerceo E, Deitelzweig SB, Sherman BM, Amin NA (2016) Multidrug-Resistant Gram-Negative Bacterial Infections in the Hospital Setting: Overview, Implications for Clinical Practice, and Emerging Treatment Options. Microb Drug Resist 22:412\u2013431. https:\/\/doi.org\/10.1089\/mdr.2015.0220","journal-title":"Microb Drug Resist"},{"key":"4310_CR5","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.cmi.2016.03.012","volume":"22","author":"M Rolain","year":"2016","unstructured":"Rolain M, Abat C, Jimeno MT, Fournier PE, Raoult D (2016) Do we need new antibiotics? Clin Microbiol Infect 22:408\u2013415. https:\/\/doi.org\/10.1016\/j.cmi.2016.03.012","journal-title":"Clin Microbiol Infect"},{"key":"4310_CR6","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.3390\/molecules25051154","volume":"25","author":"G Rastelli","year":"2020","unstructured":"Rastelli G, Pellati F, Pinzi L, Gamberini MC (2020) Repositioning Natural Products in Drug Discovery. Molecules 25:1154. https:\/\/doi.org\/10.3390\/molecules25051154","journal-title":"Molecules"},{"key":"4310_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.752174","volume":"12","author":"Y Zamami","year":"2021","unstructured":"Zamami Y, Hamano H, Niimura T, Aizawa F, Yagi K, Goda M, Izawa-Ishizawa Y, Ishizawa K (2021) Drug-Repositioning Approaches Based on Medical and Life Science Databases. Front Pharmacol 12:752174. https:\/\/doi.org\/10.3389\/fphar.2021.752174","journal-title":"Front Pharmacol"},{"key":"4310_CR8","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrd1468","volume":"3","author":"TT Ashburn","year":"2004","unstructured":"Ashburn TT, Thor KB (2004) Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov 3:673\u2013683. https:\/\/doi.org\/10.1038\/nrd1468","journal-title":"Nat Rev Drug Discov"},{"key":"4310_CR9","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/534314a","volume":"534","author":"N Nosengo","year":"2016","unstructured":"Nosengo N (2016) New tricks for old drugs. Nature 534:314\u2013316. https:\/\/doi.org\/10.1038\/534314a","journal-title":"Nature"},{"key":"4310_CR10","doi-asserted-by":"publisher","unstructured":"Gowda KRS,\u00a0Mathew BB,\u00a0Sudhamani C,\u00a0Bhojya Naik HS (2014) Mechanism of DNA Binding and Cleavage. Biomed Biotechnol 2:1\u20139. https:\/\/doi.org\/10.12691\/bb-2-1-1.","DOI":"10.12691\/bb-2-1-1"},{"issue":"50","key":"4310_CR11","doi-asserted-by":"publisher","first-page":"6414","DOI":"10.1021\/ic101791r","volume":"18","author":"PP Silva","year":"2011","unstructured":"Silva PP, Guerra W, Silveira JN, Ferreira AMC, Bortolotto T, Fischer FL, Terenzi H, Neves A, Pereira-Maria EC (2011) Two new ternary complexes of copper(II) with tetracycline or doxycycline and 1,10-phenanthroline and their potential as antitumoral: cytotoxicity and DNA cleavage. Inorg Chem 18(50):6414\u20136424. https:\/\/doi.org\/10.1021\/ic101791r","journal-title":"Inorg Chem"},{"key":"4310_CR12","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.jinorgbio.2011.01.013","volume":"105","author":"S Gama","year":"2011","unstructured":"Gama S, Mendes F, Marques F, Santos IC, Carvalho MF, Correia I, Pessoa JC, Santos I, Paulo A (2011) Copper(II) complexes with tridentate pyrazole-based ligands: synthesis, characterization, DNA cleavage activity and cytotoxicity. J Inorg Biochem 105:637\u2013644","journal-title":"J Inorg Biochem"},{"key":"4310_CR13","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3389\/fmicb.2019.00539","volume":"10","author":"MS Mulani","year":"2019","unstructured":"Mulani MS, Kamble EE, Kumkar SN, Tawre MS, Pardesi KR (2019) Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review. Front Microbiol 10:539. https:\/\/doi.org\/10.3389\/fmicb.2019.00539","journal-title":"Front Microbiol"},{"key":"4310_CR14","unstructured":"Clinical and Laboratory Standards Institute. M07-A9 Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 9th edn. Wayne, PA, USA: CLSI document. ISBN: 1\u201356238\u2013785\u20135 (2012)."},{"key":"4310_CR15","unstructured":"National Committee for Clinical Laboratory Standards. Methods for determining bactericidal activity of antimicrobial agents: approved guideline M26-A. vol. 19; No. 8. NCCLS, Wayne, USA (1999)."},{"key":"4310_CR16","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.arabjc.2015.08.008","volume":"10","author":"B Das","year":"2017","unstructured":"Das B, Dash SK, Mandal D, Ghosh T, Chattopadhyay S, Tripathy S, Das S, Dey SK, Das D, Roy S (2017) Green synthesized silver nanoparticles destroy multidrug resistant bacteria via reactive oxygen species mediated membrane damage. Arab J Chem 10:862\u2013876. https:\/\/doi.org\/10.1016\/j.arabjc.2015.08.008","journal-title":"Arab J Chem"},{"key":"4310_CR17","first-page":"365","volume-title":"Antibiotics in Laboratory Medicine","author":"V Lorian","year":"2005","unstructured":"Lorian V (2005) Antibiotics in Laboratory Medicine, 5th edn. Lippincott Williams & Wilkins, Philadelphia, PA, pp 365\u2013441","edition":"5"},{"key":"4310_CR18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1476-0711-11-18","volume":"11","author":"K Konat\u00e9","year":"2012","unstructured":"Konat\u00e9 K, Mavoungou JF, Lepengu\u00e9 AN, Aworet-Samveny RR, Hilou A, Souza A, Dicko MH, M\u2019Batchi B (2012) Antibacterial activity against \u03b2- lactamase producing Methicillin and Ampicillin-resistants Staphylococcus aureus: fractional Inhibitory Concentration Index (FICI) determination. Ann Clin Microbiol Antimicrob 11:18. https:\/\/doi.org\/10.1186\/1476-0711-11-18","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"4310_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/dkg301","volume":"52","author":"FC Odds","year":"2003","unstructured":"Odds FC (2003) Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemoth 52:1","journal-title":"J Antimicrob Chemoth"},{"key":"4310_CR20","unstructured":"Ausubel F, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K (2003) Short Protocols in Molecular Biology. John Wiley & Sons. 5."},{"key":"4310_CR21","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1139\/cjm-2020-0546","volume":"67","author":"TF Da Rosa","year":"2021","unstructured":"Da Rosa TF, Machado CS, Serafin MB, Bottega A, Coelho SS, Foletto SV, Rampelotto RF, Lorenzoni VV, Mainardi A, H\u00f6rner R (2021) Repurposing of escitalopram oxalate and clonazepam in combination with ciprofloxacin and sulfamethoxazole-trimethoprim for treatment of multidrug-resistant microorganisms and evaluation of the cleavage capacity of plasmid DNA. Can J Microbiol 67:599\u2013612. https:\/\/doi.org\/10.1139\/cjm-2020-0546","journal-title":"Can J Microbiol"},{"key":"4310_CR22","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1590\/S0103-50532010001200009","volume":"21","author":"VO Domingues","year":"2021","unstructured":"Domingues VO, H\u00f6rner R, Reetz LGB, Kuhn F, Coser VM, Rodrigues JN, Bauchspiess R, Pereira WV, Paraginski GL, Locatelli A, Fank JO, Giglio VF, H\u00f6rner M (2021) In Vitro Evaluation of Triazenes: DNA Cleavage, Antibacterial Activity and Cytotoxicity against Acute Myeloid Leukemia Cells. J Braz Chem Soc 21:2226\u20132237. https:\/\/doi.org\/10.1590\/S0103-50532010001200009","journal-title":"J Braz Chem Soc"},{"key":"4310_CR23","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.micpath.2018.11.056","volume":"127","author":"JBA Neto","year":"2019","unstructured":"Neto JBA, Josino MAA, da Silva CR, Campos RS, Nascimento FBSA, Sampaio LS, S\u00e1 LGAV, Carneiro IS, Barroso FDD, Da Silva LJ, Mesquita JRL, Cavalcanti BC, Moraes MO, J\u00fanior HVN (2019) A mechanistic approach to the in-vitro resistance modulating effects of fluoxetine against meticillin resistant Staphylococcus aureus strains. Microb Pathog 127:335\u2013340. https:\/\/doi.org\/10.1016\/j.micpath.2018.11.056","journal-title":"Microb Pathog"},{"key":"4310_CR24","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.micpath.2018.07.040","volume":"123","author":"AK De Sousa","year":"2018","unstructured":"De Sousa AK, Rocha JE, de Souza TG, de Freitas TS, Ribeiro-Filho J, Coutinho HDM (2018) New roles of fluoxetine in pharmacology: Antibacterial effect and modulation of antibiotic activity. Microb Pathog 123:368\u2013371. https:\/\/doi.org\/10.1016\/j.micpath.2018.07.040","journal-title":"Microb Pathog"},{"key":"4310_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2174\/1568026013395605","volume":"1","author":"K Poole","year":"2001","unstructured":"Poole K, Srikumar R (2001) Multidrug efflux in Pseudomonas aeruginosa: components, mechanisms and clinical significance. Curr Top Med Chem 1:59\u201371. https:\/\/doi.org\/10.2174\/1568026013395605","journal-title":"Curr Top Med Chem"},{"key":"4310_CR26","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1016\/j.ijbiomac.2020.08.184","volume":"164","author":"SBF Dos Santos","year":"2020","unstructured":"Dos Santos SBF, Pereira SA, Rodrigues FAM, Da Silva ACC, De Almeida RR, Sousa ACC, Fechine LMUD, Denardin JC, Areaneda F, S\u00e1 LGAV, Da Silva CR, J\u00fanior HVN, Ricardo NMPS (2020) Antibacterial activity of fluoxetine-loaded starch nanocapsules. Int J Biol Macromol 164:2813\u20132817. https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.08.184","journal-title":"Int J Biol Macromol"},{"key":"4310_CR27","doi-asserted-by":"crossref","first-page":"01","DOI":"10.31555\/jpbs\/2018\/6\/1\/1-4","volume":"6","author":"M Hadera","year":"2018","unstructured":"Hadera M, Mehari S, Basha NS, Amha ND, Berhane Y (2018) Study on Antimicrobial Potential of Selected Non-antibiotics and its Interaction with Conventional Antibiotics. K J Pharm Biosc 6:01\u201307","journal-title":"K J Pharm Biosc"},{"key":"4310_CR28","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1139\/cjm-2020-0546","volume":"67","author":"TF Da Rosa","year":"2021","unstructured":"Da Rosa TF, Catrine SM, Serafin MB, Bottega A, Coelho SS, Foletto VS, Rampelotto RF, Lorenzoni VV, Mainardi A, H\u00f6rner R (2021) Repurposing of escitalopram oxalate and clonazepam in combination with ciprofloxacin and sulfamethoxazole-trimethoprim for treatment of multidrug-resistant microorganisms and evaluation of the cleavage capacity of plasmid DNA. Can J Microbiol 67:599\u2013612. https:\/\/doi.org\/10.1139\/cjm-2020-0546","journal-title":"Can J Microbiol"},{"key":"4310_CR29","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s00044-019-02470-x","volume":"29","author":"CS Machado","year":"2020","unstructured":"Machado CS, Da Rosa TF, Serafin MB, Bottega A, Coelho SS, Foletto VS, Rampelotto RF, Lorenzoni VV, Marion SL, H\u00f6rner R (2020) In vitro evaluation of the antibacterial activity of amitriptyline and its synergistic effect with ciprofloxacin, sulfamethoxazole\u2013trimethoprim, and colistin as an alternative in drug repositioning. Med Chem Res 29:166\u2013177. https:\/\/doi.org\/10.1007\/s00044-019-02470-x","journal-title":"Med Chem Res"},{"key":"4310_CR30","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1007\/s00134-020-06022-5","volume":"46","author":"W Alhazzani","year":"2020","unstructured":"Alhazzani W, Moller MH, Arabi YM (2020) Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med 46:854\u2013887. https:\/\/doi.org\/10.1007\/s00134-020-06022-5","journal-title":"Intensive Care Med"},{"key":"4310_CR31","doi-asserted-by":"crossref","unstructured":"Rawson TM,\u00a0Moore LSP,\u00a0Zhu N, Ranganathan N, Skolimowska K, Gilchrist M, Satta G, Cooke G, Holmes A (2020) Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing.","DOI":"10.1093\/cid\/ciaa530"},{"key":"4310_CR32","doi-asserted-by":"publisher","unstructured":"Clin Infect Dis 71:2459\u20132468. https:\/\/doi.org\/10.1093\/cid\/ciaa530.","DOI":"10.1093\/cid\/ciaa530"},{"key":"4310_CR33","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/j.cmi.2020.07.016","volume":"26","author":"BJ Langford","year":"2020","unstructured":"Langford BJ, So M, Raybardhan S, Leung V, Westwood D, MacFadden DR, Soucy JR, Daneman N (2020) Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect 26:1622\u20131629. https:\/\/doi.org\/10.1016\/j.cmi.2020.07.016","journal-title":"Clin Microbiol Infect"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-025-04310-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-025-04310-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-025-04310-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T01:23:15Z","timestamp":1757294595000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-025-04310-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,26]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["4310"],"URL":"https:\/\/doi.org\/10.1007\/s00284-025-04310-1","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"type":"print","value":"0343-8651"},{"type":"electronic","value":"1432-0991"}],"subject":[],"published":{"date-parts":[[2025,7,26]]},"assertion":[{"value":"28 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declares that they have no confict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"411"}}